Increasingly, agricultural scientists in Asia and Africa are using the gene-editing tool CRISPR to develop disease-resistant, high-yield crop varieties. Many, especially those in government research laboratories, are underestimating the importance of the patent and licensing rules that surround tools such as CRISPR.
- Access the most recent journalism from Nature’s award-winning team
- Explore the latest features & opinion covering groundbreaking research
or
Competing Interests
The author declares no competing interests.